Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.85M | $63.0M | 39.93% | -- | 2026-03-31 |
| 5AM Venture Management, LLC | 2.35M | $15.0M | 9.54% | -- | 2026-03-31 |
| VR ADVISER, LLC | 1.61M | $10.0M | 6.52% | -- | 2026-03-31 |
| FRANKLIN RESOURCES INC | 520.3K | $3.0M | 2.11% | -- | 2026-03-31 |
| Revelation Capital Management, LLC | 299.3K | $1.0M | 1.21% | -- | 2026-03-31 |
| BlackRock, Inc. | 213.4K | $1.0M | 0.86% | +850 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 207.7K | $1.0M | 0.84% | -- | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 194.1K | $1.0M | 0.79% | -- | 2026-03-31 |
| Propel Bio Management, LLC | 146.4K | -- | 0.59% | -- | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 123.3K | -- | 0.50% | -93.8K | 2026-03-31 |
